American Gastroenterological Association GI Opportunity Fund 1
Overview
American Gastroenterological Association GI Opportunity Fund 1 is a venture capital fund established by the American Gastroenterological Association in partnership with Varia Ventures to invest in early-stage companies in the gastroenterology sector.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EndoSound, Inc. | Oct 2023 | Series A | Co-investor |
| EvoEndo | Apr 2023 | Series A Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is American Gastroenterological Association GI Opportunity Fund 1 based?
American Gastroenterological Association GI Opportunity Fund 1 is headquartered in Buffalo, New York, United States.
When was American Gastroenterological Association GI Opportunity Fund 1 founded?
American Gastroenterological Association GI Opportunity Fund 1 was founded in 2022.
How many portfolio companies does American Gastroenterological Association GI Opportunity Fund 1 have?
American Gastroenterological Association GI Opportunity Fund 1 has 2 portfolio companies in Caplight's dataset.
What are some companies in American Gastroenterological Association GI Opportunity Fund 1's portfolio?
Portfolio companies visible on Caplight include EndoSound, Inc., EvoEndo.
What was American Gastroenterological Association GI Opportunity Fund 1's most recent investment shown here?
American Gastroenterological Association GI Opportunity Fund 1's most recent investment in this portfolio sample was in EndoSound, Inc. in 2023.
What sectors does American Gastroenterological Association GI Opportunity Fund 1 focus on?
American Gastroenterological Association GI Opportunity Fund 1 focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does American Gastroenterological Association GI Opportunity Fund 1 focus on?
American Gastroenterological Association GI Opportunity Fund 1 typically invests at the Early stage.